首页|循证干预对胶质瘤手术患者术中获得性压力性损伤的影响

循证干预对胶质瘤手术患者术中获得性压力性损伤的影响

扫码查看
目的 探讨循证干预对胶质瘤手术患者术中获得性压力性损伤(IAPI)的影响.方法 根据干预方式的不同将120例胶质瘤手术患者分为常规组(n=55)和循证组(n=65),常规组患者接受常规干预,循证组患者接受循证干预.比较两组患者受压部位皮肤温度、湿度及术后皮肤异常情况.结果 术毕,两组患者肩部、髋部、足跟皮肤温度、湿度均高于本组术前,循证组患者肩部、髋部、足跟皮肤温度、湿度均低于常规组,差异均有统计学意义(P﹤0.05).循证组患者术后皮肤异常总发生率为27.70%,低于常规组患者的45.45%,差异有统计学意义(P﹤0.05).结论 循证干预应用于胶质瘤手术患者中,可改善其受压部位皮肤表面的温度、湿度,降低IAPI发生风险.
Effect of evidence-based intervention on intraoperative acquired pressure injury in patients with glioma undergoing surgery
Objective To investigate the effect of evidence-based intervention on intraoperative acquired pressure in-jury(IAPI)in patients with glioma undergoing surgery.Method According to different intervention methods,120 pa-tients with glioma who underwent surgery were divided into conventional group(n=55)and evidence-based group(n=65).Patients in the conventional group received conventional intervention,and patients in the evidence-based group re-ceived evidence-based intervention.The skin temperature and humidity of the pressure site and the abnormal skin condi-tion after surgery were compared between the two groups.Result After operation,the skin temperature and humidity of shoulder,hip and heel in two groups were higher than those before operation,and the skin temperature and humidity of shoulder,hip and heel in evidence-based group were lower than those in conventional group,the differences were statisti-cally significant(P<0.05).The total incidence of skin abnormality after surgery in evidence-based group was 27.70%,which was lower than 45.45%in conventional group,and the difference was statistically significant(P<0.05).Conclusion The application of evidence-based intervention in patients with glioma undergoing surgery can improve the temperature and humidity of the skin surface,reduce the incidence of IAPI.

evidence-based interventiongliomaintraoperative acquired pressure injury

于宁二、尚坤、单单单、支慧、刘翱搏

展开 >

河南省人民医院麻醉与围术期医学科,郑州 450000

循证干预 胶质瘤 术中获得性压力性损伤

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(22)